Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Udgivelsesdato: 2007-Sep
OriginalsprogEngelsk
TidsskriftCancer Immunology, Immunotherapy
Vol/bind56
Udgave nummer9
Sider (fra-til)1485-99
Antal sider14
ISSN0340-7004
DOI
StatusUdgivet - 2007

ID: 8442428